Head of Research

Jon Terrett, Ph.D.

Mgmt Jonathan Terrett new

Jon Terrett, Ph.D. has served as our Head of Research since 2017. He has an extensive track record of discovering and progressing immuno-oncology drug candidates into the clinic. Prior to joining our company, Jon served as the Vice President of Oncology Discovery for CytomX, an oncology-focused biotechnology company focused on developing a novel class of antibody therapeutics. In addition, Jon has held various R&D leadership roles in biopharma, including serving as the Chief Scientific Officer at Oxford Biotherapeutics, and as a director at various biotechnology companies including Medarex, CellTech and Oxford Glycosciences. Jon received a Ph.D. in genetics at the University of Nottingham and a B.S. in genetics at the University of Sheffield.

Previous Next

You are now leaving the CRISPR Therapeutics website.

CRISPR Therapeutics is not responsible for the content or availability of third-party sites.